Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the colon.
Biomarker and diagnostic research for neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include medical devices. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
209 publications have been identified in PubMed for neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor. Kisho has analyzed 137 by research type. Research spans Review / Meta-Analysis (28%), Clinical Trial Publication (19%), and Diagnostic / Biomarker (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 39 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 10:30 PM UTC
28%
Clinical study results | 26 | 19% |
Testing and diagnosis research | 25 | 18% |
Disease patterns and progression | 25 | 18% |
Laboratory research | 18 | 13% |
Patient case studies | 3 | 2% |
New treatment approaches | 1 | 1% |
Sheng YH (2026). [PMID: 41693974](https://pubmed.ncbi.nlm.nih.gov/41693974/). *World J Gastroenterol*. [Review / Meta-Analysis]
van den Heerik ASVM (2026). [PMID: 41449145](https://pubmed.ncbi.nlm.nih.gov/41449145/). *Lancet Oncol*. [Clinical Trial Publication]
Xu H (2026). [PMID: 42200202](https://pubmed.ncbi.nlm.nih.gov/42200202/). *Front Genet*. [Case Report / Case Series]
Scuderi S (2026). [PMID: 41002165](https://pubmed.ncbi.nlm.nih.gov/41002165/). *J Natl Cancer Inst*. [Diagnostic / Biomarker]
Cella L (2026). [PMID: 42041162](https://pubmed.ncbi.nlm.nih.gov/42041162/). *Future Oncol*. [Review / Meta-Analysis]
Rameh V (2026). [PMID: 40962421](https://pubmed.ncbi.nlm.nih.gov/40962421/). *AJNR Am J Neuroradiol*. [Diagnostic / Biomarker]
Tanguy R (2026). [PMID: 42115465](https://pubmed.ncbi.nlm.nih.gov/42115465/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Ottaiano A (2026). [PMID: 41898857](https://pubmed.ncbi.nlm.nih.gov/41898857/). *Genes (Basel)*. [Review / Meta-Analysis]
Talavera Cobo V (2026). [PMID: 41718112](https://pubmed.ncbi.nlm.nih.gov/41718112/). *Med Sci (Basel)*. [Diagnostic / Biomarker]
Bancroft EK (2026). [PMID: 41714267](https://pubmed.ncbi.nlm.nih.gov/41714267/). *Eur Urol*. [Diagnostic / Biomarker]